Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chitosans for gene delivery.

G Borchard1

  • 1Leiden/Amsterdam Center for Drug Research, Division of Pharmaceutical Technology, PO Box 9502, 2300 RA Leiden, The Netherlands. borchard@lacdr.leidenuniv.nl

Advanced Drug Delivery Reviews
|November 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Considerations for the delivery of STING ligands in cancer immunotherapy.

Journal of controlled release : official journal of the Controlled Release Society·2021
Same author

Encapsulation of VEGF<sub>165</sub> into magnetic PLGA nanocapsules for potential local delivery and bioactivity in human brain endothelial cells.

Journal of materials chemistry. B·2020
Same author

Equivalence of glatiramer acetate products: challenges in assessing pharmaceutical equivalence and critical clinical performance attributes.

Expert opinion on drug delivery·2017
Same author

Association of chitosan and aluminium as a new adjuvant strategy for improved vaccination.

International journal of pharmaceutics·2017
Same author

Peptide-decorated chitosan derivatives enhance fibroblast adhesion and proliferation in wound healing.

Carbohydrate polymers·2016
Same author

Arming embolic beads with anti-VEGF antibodies and controlling their release using LbL technology.

Journal of controlled release : official journal of the Controlled Release Society·2016
Same journal

Silicone oil in protein drug products and its implications for formulation stability.

Advanced drug delivery reviews·2026
Same journal

Targeted delivery of proteolysis-targeting chimeras (PROTAC) and molecular glue degraders (MGD).

Advanced drug delivery reviews·2026
Same journal

Lysosome-targeting degrader delivery system: from formulation design to biomedical applications.

Advanced drug delivery reviews·2026
Same journal

Anti-PEG antibodies in nanomedicine: Mechanisms, risks, and opportunities.

Advanced drug delivery reviews·2026
Same journal

Optimizing macrophage-targeted intracellular delivery systems for safe and effective immunotherapies.

Advanced drug delivery reviews·2026
Same journal

Light-controlled CRISPR-dCas9 epigenome editing: advanced drug-delivery strategies and oncology applications.

Advanced drug delivery reviews·2026
See all related articles

Chitosan and its derivatives show promise for non-viral gene delivery. This review explores recent advancements and transfection studies using chitosan-based gene delivery systems.

Area of Science:

  • Biomaterials Science
  • Gene Therapy
  • Polymer Chemistry

Background:

  • Non-viral gene delivery faces challenges including complex size, stability, toxicity, and cellular processing.
  • Cationic polymers are crucial for condensing DNA in non-viral gene delivery systems.
  • Chitosan is a biocompatible polysaccharide with potential for gene delivery applications.

Purpose of the Study:

  • To review recent advances in using chitosan and its derivatives for non-viral gene delivery.
  • To provide an overview of current transfection studies employing chitosan-based agents.
  • To highlight the potential of chitosan in overcoming gene delivery barriers.

Main Methods:

  • Literature review of recent studies on chitosan and gene delivery.
  • Analysis of factors affecting non-viral gene delivery efficiency with chitosan.

Related Experiment Videos

  • Examination of transfection studies utilizing chitosan derivatives.

    • Main Results:

    • Chitosan and its derivatives demonstrate potential as effective DNA-condensing agents.
    • Various chitosan derivatives are being explored to optimize complex properties like size and stability.
    • Studies show promising transfection efficiencies and reduced toxicity with modified chitosans.

    Conclusions:

    • Chitosan and its derivatives represent a viable and improvable platform for non-viral gene delivery.
    • Further research into chitosan modifications can enhance gene delivery efficacy and safety.
    • Chitosan-based systems offer a promising alternative to viral vectors in gene therapy.